EPCAM and hepatocellular carcinoma: Downregulated miR‐26b‐5p led to increased EpCAM transcription and a population of EpCAM+ HCC cells, as well as the overexpression of NANOG, OCT4, and SOX2, the direct targets of EpCAM [74].